BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 33164830)

  • 21. The Role of Long Non-Coding RNAs in Cardiovascular Diseases.
    Le LTT; Nhu CXT
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The functions and networks of non-coding RNAs in the pathogenesis of Rheumatoid Arthritis.
    Liu J; Song S; Zhao R; Zhang HY; Zhang SX
    Biomed Pharmacother; 2023 Jul; 163():114707. PubMed ID: 37087979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noncoding RNAs in Cardiovascular Disease: Pathological Relevance and Emerging Role as Biomarkers and Therapeutics.
    Gangwar RS; Rajagopalan S; Natarajan R; Deiuliis JA
    Am J Hypertens; 2018 Jan; 31(2):150-165. PubMed ID: 29186297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-coding RNAs and Coronary Artery Disease.
    Cardona-Monzonís A; García-Giménez JL; Mena-Mollá S; Pareja-Galeano H; de la Guía-Galipienso F; Lippi G; Pallardó FV; Sanchis-Gomar F
    Adv Exp Med Biol; 2020; 1229():273-285. PubMed ID: 32285418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases.
    Zhang C; Niu K; Lian P; Hu Y; Shuai Z; Gao S; Ge S; Xu T; Xiao Q; Chen Z
    Hypertension; 2021 Jul; 78(1):16-29. PubMed ID: 34058852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Coding RNA and Diabetic Kidney Disease.
    Ren H; Wang Q
    DNA Cell Biol; 2021 Apr; 40(4):553-567. PubMed ID: 33733861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Illuminating the Molecular Intricacies of Exosomes and ncRNAs in Cardiovascular Diseases: Prospective Therapeutic and Biomarker Potential.
    Khan FB; Uddin S; Elderdery AY; Goh KW; Ming LC; Ardianto C; Palakot AR; Anwar I; Khan M; Owais M; Huang CY; Daddam JR; Khan MA; Shoaib S; Khursheed M; Reshadat S; Khayat Kashani HR; Mirza S; Khaleel AA; Ayoub MA
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implication of regulatory networks of long noncoding RNA/circular RNA-miRNA-mRNA in diabetic cardiovascular diseases.
    Xiong W; Yao M; Yang Y; Qu Y; Qian J
    Epigenomics; 2020 Nov; 12(21):1929-1947. PubMed ID: 33245677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances on the roles of LncRNAs in cardiovascular disease.
    Fang Y; Xu Y; Wang R; Hu L; Guo D; Xue F; Guo W; Zhang D; Hu J; Li Y; Zhang W; Zhang M
    J Cell Mol Med; 2020 Nov; 24(21):12246-12257. PubMed ID: 32969576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-coding RNAs in diabetes mellitus and diabetic cardiovascular disease.
    Li C; Wang D; Jiang Z; Gao Y; Sun L; Li R; Chen M; Lin C; Liu D
    Front Endocrinol (Lausanne); 2022; 13():961802. PubMed ID: 36147580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circular RNA in cardiovascular disease.
    Altesha MA; Ni T; Khan A; Liu K; Zheng X
    J Cell Physiol; 2019 May; 234(5):5588-5600. PubMed ID: 30341894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research progress in the role of non-coding RNAs and embryo implantation.
    Liu L; Guo J; Gao W; Gao M; Ma X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1377-1387. PubMed ID: 38044649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MIAT, a potent CVD-promoting lncRNA.
    Yang C; Zhang Y; Yang B
    Cell Mol Life Sci; 2021 Dec; 79(1):43. PubMed ID: 34921634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular noncoding RNAs as potential therapies and circulating biomarkers for cardiovascular diseases.
    Bayoumi AS; Aonuma T; Teoh JP; Tang YL; Kim IM
    Acta Pharmacol Sin; 2018 Jul; 39(7):1100-1109. PubMed ID: 29565037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Special Issue "The Role of Non-Coding RNAs Involved in Cardiovascular Diseases and Cellular Communication".
    Climent M; García-Giménez JL
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of noncoding RNAs in regulation of cardiac cell death and cardiovascular diseases.
    Dong Y; Liu C; Zhao Y; Ponnusamy M; Li P; Wang K
    Cell Mol Life Sci; 2018 Jan; 75(2):291-300. PubMed ID: 28913665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The circulating non-coding RNA landscape for biomarker research: lessons and prospects from cardiovascular diseases.
    E S; Costa MC; Kurc S; Drożdż A; Cortez-Dias N; Enguita FJ
    Acta Pharmacol Sin; 2018 Jul; 39(7):1085-1099. PubMed ID: 29877319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noncoding RNAs as Key Regulators for Cardiac Development and Cardiovascular Diseases.
    Kawaguchi S; Moukette B; Hayasaka T; Haskell AK; Mah J; Sepúlveda MN; Tang Y; Kim IM
    J Cardiovasc Dev Dis; 2023 Apr; 10(4):. PubMed ID: 37103045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA (Epi)genetics in cardiovascular diseases.
    Elia L; Condorelli G
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):11-6. PubMed ID: 26205296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling.
    Gao J; Xu W; Wang J; Wang K; Li P
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.